Cell Applications specializes in advanced cell culture technologies, particularly focusing on the development and provision of various human and animal cell types for research and drug discovery. Their offerings include iPSC-derived human hepatocytes, which are utilized to create a novel 3D liver model capable of secreting albumin, producing urea, and exhibiting CYP3A4 activity. Additionally, they provide human brown fat cells derived from pluripotent stem cells, which are essential for studying thermogenic factors in brown fat development. The company also offers a range of ocular cells and media, including corneal epithelial cells, aimed at enhancing ophthalmology research and drug discovery efforts.

Furthermore, Cell Applications provides high-purity primary cell types, including diseased gastrointestinal epithelial cells from conditions such as Crohn's disease and ulcerative colitis. Their products are designed to serve as valuable in vitro models for investigating disease mechanisms and facilitating drug discovery. The company emphasizes quality control, with a certified cGMP facility ensuring that their cell culture media and reagents meet rigorous standards. Their extensive catalog and custom services cater to a global clientele, supporting a wide array of research applications in cell biology and disease modeling.

United States

Global Leadership in Primary Cells: Excellence in cell isolation, 3D bioprinting, tissue engineering, 3D cell models, stem cells, optimized culture media and more.  CAI's products and custom services support basic life science research and biopharmaceutical drug discovery.  Our Center for Primary Cell Innovation pushes the edges of technology, with regular advancements developed in collaboration with academic & industry experts.

Cell Applications

Company Details